Drug Information
Drug (ID: DG00465) and It's Reported Resistant Information
Name |
Carboplatin/Paclitaxel
|
||||
---|---|---|---|---|---|
Drug Resistance Disease(s) |
Disease(s) with Clinically Reported Resistance for This Drug
(1 diseases)
Ovarian cancer [ICD-11: 2C73]
[1]
|
Type(s) of Resistant Mechanism of This Drug
UAPP: Unusual Activation of Pro-survival Pathway
Drug Resistance Data Categorized by Their Corresponding Diseases
ICD-02: Benign/in-situ/malignant neoplasm
Ovarian cancer [ICD-11: 2C73]
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Unusual Activation of Pro-survival Pathway (UAPP) | ||||
Key Molecule: Carboxylesterase 4A (CES4A) | [1] | |||
Molecule Alteration | Missense mutation | p.P55S |
||
Resistant Disease | Ovarian cancer [ICD-11: 2C73.0] | |||
Experimental Note | Identified from the Human Clinical Data | |||
Cell Pathway Regulation | AXLK signaling pathway | Activation | hsa01521 | |
In Vitro Model | Plasma | Blood | Homo sapiens (Human) | N.A. |
Experiment for Molecule Alteration |
Circulating-free DNA assay; Whole exome sequencing assay | |||
Mechanism Description | Quantification of allele fractions in plasma identified increased representation of mutant alleles in association with emergence of therapy resistance. | |||
Key Molecule: Mitotic checkpoint serine/threonine-protein kinase BUB1 (BUB1) | [1] | |||
Molecule Alteration | Missense mutation | p.M889K |
||
Resistant Disease | Ovarian cancer [ICD-11: 2C73.0] | |||
Experimental Note | Identified from the Human Clinical Data | |||
Cell Pathway Regulation | AXLK signaling pathway | Activation | hsa01521 | |
In Vitro Model | Plasma | Blood | Homo sapiens (Human) | N.A. |
Experiment for Molecule Alteration |
Circulating-free DNA assay; Whole exome sequencing assay | |||
Mechanism Description | Quantification of allele fractions in plasma identified increased representation of mutant alleles in association with emergence of therapy resistance. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.